Article
Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response.
Nature cancer - 1 May 2021
Scheller Marina, Ludwig Anne Kathrin, Göllner Stefanie, Rohde Christian, Krämer Stephen, Stäble Sina, Janssen Maike, Müller James-Arne, He Lixiazi, Bäumer Nicole, Arnold Christian, Gerß Joachim, Schönung Maximilian, Thiede Christian, Niederwieser Christian, Niederwieser Dietger, Serve Hubert, Berdel Wolfgang E, Thiem Ulrich, Hemmerling Inga, Leuschner Florian, Plass Christoph, Schlesner Matthias, Zaugg Judith, Milsom Michael D, Trumpp Andreas, Pabst Caroline, Lipka Daniel B, Müller-Tidow Carsten
Abstract excerpt
Somatic mutations in DNA methyltransferase 3A (DNMT3A) are among the most frequent alterations in clonal hematopoiesis (CH) and acute myeloid leukemia (AML), with a hotspot in exon 23 at arginine 882 (DNMT3AR882). Here, we demonstrate that DNMT3AR882H-dependent CH and AML cells are specifically susceptible to the hypomethylating agent azacytidine (AZA). Addition of AZA to chemotherapy prolonged AML survival...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
